Applied DNA plans public offering of its shares
20/12/2018
The company said it would use the proceeds of this offering for working capital, capital expenditures, business development and research and development costs.
It explained that the offering is subject to market conditions and said it could offer no assurance as to whether or when the offering may be completed.